Websites, domains, hosts that links to wwwext.amgen.com
Our database shows, that the website wwwext.amgen.com is linked by a total of 38 websites.
Number of websites/domains displayed: 38
Results found: 38
Websites discovered:
Amgen Pipelinehttp://pageoverview.com/website-report/amgenpipeline.com
- Expected expiration: August 2nd in 2018
- Creation date: August 2nd in 2014
- Renew date: July 1st in 2017
Welcome to Amgenhttp://pageoverview.com/website-report/proliasupport.com
- Expected expiration: June 4th in 2018
- Creation date: June 4th in 2009
- Renew date: May 3rd in 2017
Amgen Brasilhttp://pageoverview.com/website-report/amgenbrasil.com.br
- Expected expiration: April 19th in 2018
- Creation date: April 19th in 2012
- Renew date: April 10th in 2017
ITP Treatment - ITP (immune thrombocytopenia) & Nplate® (romiplostim)http://pageoverview.com/website-report/nplate.com
Nplate® (romiplostim) - The Official Site - Learn more about ITP (immune thrombocytopenia) and Nplate®, a treatment for adults with chronic ITP.
- Expected expiration: January 12th in 2018
- Creation date: January 12th in 2008
- Renew date: December 11th in 2016
aranesp.comhttp://pageoverview.com/website-report/aranesp.com
- Expected expiration: September 13th in 2017
- Creation date: September 13th in 1999
- Renew date: August 12th in 2016
Chronic Heart Failure | Corlanor® (ivabradine) Official Sitehttp://pageoverview.com/website-report/corlanor.com
Corlanor® (ivabradine) is a chronic heart failure treatment. Learn about Chronic HF symptoms and causes. Get the complete details on Corlanor® benefits and safety.
- Expected expiration: March 5th in 2019
- Creation date: March 5th in 2009
- Renew date: February 1st in 2017
Enbrel® (etanercept)http://pageoverview.com/website-report/enbrel.com
Enbrel® (etanercept) is a prescription medicine used to treat five chronic diseases, including moderate to severe plaque psoriasis and rheumatoid arthritis.
- Expected expiration: February 11th in 2018
- Creation date: February 11th in 1999
- Renew date: January 10th in 2017
- Google Analytics: 70400828-1
Welcome to Amgenhttp://pageoverview.com/website-report/amgenfirststep.com
- Expected expiration: October 22nd in 2018
- Creation date: October 22nd in 2010
- Renew date: September 21st in 2017
Neulasta® (pegfilgrastim) | G-CSF Injectionhttp://pageoverview.com/website-report/neulasta.com
Learn about Neulasta® (pegfilgrastim) and Neulasta® Onpro™, the on-body injector designed to administer Neulasta®.
- Expected expiration: January 11th in 2018
- Creation date: January 11th in 2002
- Renew date: December 10th in 2016
Parsabiv™ (etelcalcetide)http://pageoverview.com/website-report/parsabiv.com
- Expected expiration: December 9th in 2018
- Creation date: December 9th in 2014
- Renew date: November 7th in 2017
Psoriasis Connecthttp://pageoverview.com/website-report/psoriasisconnect.com
Find psoriasis information, including types of psoriasis, symptoms, treatment options, patient stories, and more.
- Expected expiration: March 21st in 2018
- Creation date: March 21st in 2003
- Renew date: February 17th in 2017
Amgen Italiahttp://pageoverview.com/website-report/amgen.it
- Expected expiration: June 7th in 2018
- Creation date: November 6th in 1998
- Renew date: June 23rd in 2017
- Google Analytics: 109443116-1
BiTE® Immunotherapy: Official sitehttp://pageoverview.com/website-report/biteantibodies.com
Learn how investigational BiTE® antibodies can activate endogenous T cells to target malignant cells. Watch the proposed mechanism of BiTE® video.
- Expected expiration: October 30th in 2017
- Creation date: October 30th in 2013
- Renew date: September 28th in 2016
Amgen Business Developmenthttp://pageoverview.com/website-report/amgenbd.com
Amgen is committed to partnering with innovators in the fight against serious illness. Amgen’s business development team brings together deep scientific, financial, deal, partnership, and integration expertise—along with an ability to bring the right people inside Amgen to the right conversations. Business Development plays a critical role in the execution of Amgen’s growth strategy. From the early-stage innovations we fund through Amgen Ventures to the integration and alliance management work we engage in once an agreement is reached, Amgen Business Development is organized to effectively manage the process of working with partners every step of the way.
- Expected expiration: June 10th in 2018
- Creation date: June 10th in 2014
- Renew date: May 9th in 2017
Biotechnology by Amgen | Biologic Innovation, Quality & Reliabilityhttp://pageoverview.com/website-report/amgenbiotech.com
Biotechnology by Amgen educational program is about how we develop and manufacture high-quality, reliably available biologic medications. Our processes make us better.
- Expected expiration: April 16th in 2018
- Creation date: April 16th in 2013
- Renew date: March 15th in 2017
- Google Analytics: 55090708-1
Repatha® (evolocumab) Official HCP Site | Repatha® (evolocumab)http://pageoverview.com/website-report/repathahcp.com
Learn about PCSK9 inhibitor Repatha®. Or get patients started with insurance verification, and financial assistance.
- Expected expiration: February 4th in 2023
- Creation date: February 4th in 2015
- Renew date: January 3rd in 2018
Amgen Canadahttp://pageoverview.com/website-report/amgen.ca
- Expected expiration: July 19th in 2018
- Creation date: October 5th in 2000
- Renew date: June 17th in 2017
- Google Analytics: 108582245-1
www.sensiparhcp.comhttp://pageoverview.com/website-report/sensiparhcp.com
- Expected expiration: May 13th in 2019
- Creation date: May 13th in 2009
- Renew date: April 10th in 2012
Amgen Education - Landing Pagehttp://pageoverview.com/website-report/amgeneducation.com
- Expected expiration: January 16th in 2023
- Creation date: January 16th in 2013
- Renew date: December 15th in 2017
High Cholesterol Treatment | Lower LDL | Repatha® (evolocumab)http://pageoverview.com/website-report/repatha.com
Repatha® (evolocumab) is used along with diet & maximally tolerated statin for high LDL cholesterol.
- Expected expiration: November 22nd in 2017
- Creation date: November 22nd in 2013
- Renew date: October 21st in 2016
Amgen Singaporehttp://pageoverview.com/website-report/amgen.com.sg
- Creation date: January 9th in 2016
- Expected expiration: January 9th in 2020
- Google Analytics: 86420503-1
Multiple Myeloma: International Myeloma Foundation |http://pageoverview.com/website-report/myeloma.org
The International Myeloma Foundation is dedicated to finding a cure for multiple myeloma through global research, and offers myeloma treatment guidelines and support.
- Expected expiration: January 22nd in 2022
- Creation date: January 21st in 1997
- Renew date: November 23rd in 2016
- Google Analytics: 6046850-1
Welcome to Breakaway from Heart Disease™http://pageoverview.com/website-report/breakawayfromheartdisease.com
- Expected expiration: February 26th in 2020
- Creation date: February 26th in 2016
- Renew date: January 25th in 2018
American Nephrology Nurses Associationhttp://pageoverview.com/website-report/annanurse.org
- Expected expiration: April 16th in 2021
- Creation date: April 16th in 1999
- Renew date: February 16th in 2016
- Google Analytics: 23107112-1
Amgen UK & IEhttp://pageoverview.com/website-report/amgen.co.uk
- Renew date: February 8th in 2018
- Google Analytics: 109440077-1
Enbrel® (etanercept) - ¡Próximamente!http://pageoverview.com/website-report/enbrelenespanol.com
Use the Enbrel® (etanercept) site map to find the page you're looking for on Enbrel.com.
- Expected expiration: June 26th in 2018
- Creation date: June 26th in 2006
- Renew date: May 25th in 2017
Vectibix® (panitumumab) for Wild-Type RAS mCRC | HCPhttp://pageoverview.com/website-report/vectibix.com
Learn about Vectibix® (panitumumab): an FDA-approved 1st- & 3rd-line treatment option for patients with WT RAS metastatic colorectal cancer (mCRC).
- Expected expiration: October 5th in 2018
- Creation date: October 5th in 2005
- Renew date: September 3rd in 2017
Amgen Scholarshttp://pageoverview.com/website-report/amgenscholars.eu
The Amgen Scholars Program provides hundreds of selected undergraduates with the opportunity to engage in a hands-on research experience at many of the world’s leading institutions.
- Google Analytics: 27399718-1
Science of Migraine | For Health Care Professionalshttp://pageoverview.com/website-report/scienceofmigraine.com
Find migraine disease data and information on migraine pathophysiology, as well as an understanding of current migraine management, here.
- Expected expiration: May 5th in 2026
- Creation date: May 5th in 2016
- Renew date: May 5th in 2016
NEUPOGEN® (filgrastim) | Granulocyte Colony-Stimulating Factorhttp://pageoverview.com/website-report/neupogenhcp.com
Learn about NEUPOGEN® (filgrastim), a daily injectable granulocyte colony-stimulating factor (GCS-F) available in two administration options.
- Expected expiration: December 14th in 2018
- Creation date: December 14th in 2012
- Renew date: November 12th in 2017
Amgen Scholarshttp://pageoverview.com/website-report/amgenscholars.com
The Amgen Scholars Program provides hundreds of selected undergraduates with the opportunity to engage in a hands-on research experience at many of the world’s leading institutions.
- Expected expiration: May 26th in 2018
- Creation date: May 26th in 2006
- Renew date: April 24th in 2017
- Google Analytics: 27399718-1
Amgen Safety Net Foundationhttp://pageoverview.com/website-report/amgensafetynetfoundation.com
- Expected expiration: September 28th in 2018
- Creation date: September 28th in 2006
- Renew date: August 27th in 2017
KYPROLIS® (carfilzomib) for Relapsed Multiple Myeloma Treatmenthttp://pageoverview.com/website-report/kyprolis.com
KYPROLIS® (carfilzomib) is a treatment option for people who have already received 1 or more previous treatments for relapsed multiple myeloma. Learn how KYPROLIS may help.
- Expected expiration: May 11th in 2017
- Creation date: May 11th in 2010
- Renew date: November 10th in 2015